Alireza Nazeri, MD, FACC, FHRS
Board-Certified Cardiac Electrophysiologist in Houston, TX
Dr. Alireza Nazeri is a clinical cardiologist and cardiac electrophysiologist specializing in the diagnosis and treatment of heart rhythm disorders (arrhythmias). He is board certified in cardiovascular disease and in clinical cardiac electrophysiology by the American Board of Internal Medicine.
Dr. Nazeri completed his advanced training in adult cardiology and interventional cardiac electrophysiology at Texas Heart Institute, in Houston, where he is a member of the professional staff. He provides cardiac electrophysiology services at Mobitz Heart and Rhythm Center PLLC at Texas Medical Center and affiliated hospitals in the Houston metropolitan area.
Dr. Nazeri has been and continues to be involved in advanced research in the fields of cardiology and cardiac electrophysiology. His research has been published in prestigious medical journals and presented at national and international cardiology conferences. He is an active fellow of the Heart Rhythm Society (FHRS) and of the American College of Cardiology (FACC).
Dr. Nazeri’s comprehensive services span the full spectrum of arrhythmia-related care, from screening and prevention to diagnosis and treatment of heart rhythm disorders. His areas of expertise include:
- Cardiac arrhythmias: Diagnosis and treatment of heart rhythm disorders. Dr. Nazeri performs electrophysiology studies and ablation of arrhythmias such as atrial fibrillation (AFib), atrial flutter, supraventricular tachycardia, and ventricular arrhythmias.
- Syncope (fainting): Consultation, diagnosis, and treatment of underlying heart rhythm disorders in patients who experience syncope
- Heart rhythm devices: Implantation, management, and monitoring of implantable heart rhythm devices, including transvenous and leadless pacemakers, implantable cardiac defibrillators (ICDs), biventricular AICD/pacemakers (cardiac resynchronization therapy), and implantable loop recorders. Dr. Nazeri also performs removal of infected or malfunctioning heart rhythm devices.
- Left atrial appendage exclusion for the prevention of stroke in patients who cannot tolerate anticoagulation therapy (blood thinners)
- Evaluation and treatment of heart rhythm disorders in patients with hereditary (congenital) heart disease.
Areas of Special Interest
- Atrial fibrillation
- Stroke prevention
- Heart failure and arrhythmia
- Early detection of arrhythmias
- Prevention of sudden cardiac death
- Public health education
Research & Publications
Mehdi Razavi, Alireza Nazeri, Ali Massumi, Samuel J. Asirvatham. Cardiac Rhythm Devices: A Case Based Approach, Demos Medical Publishing, New York, NY, 2011.
Nazeri A, Ganapathy AV, Massumi A, Massumi M, Tuzun E, Stainback R, Segura AM, Elayda MA, Razavi M.Effect of botulinum toxin on inducibility and maintenance of atrial fibrillation in ovine myocardial tissue.Pacing Clin Electrophysiol. 2017 Jun;40(6):693-702. doi:10.1111/pace.13079. Epub 2017 May 16.
Nazeri A, Elayda MA, Segura AM, Stainback RF, Nathan J, Lee VV, Bove C, Sampaio L, Grace B, Massumi A, Razavi M. Comparative Efficacy of Nebivolol and Metoprolol to Prevent Tachycardia-Induced Cardiomyopathy in a Porcine Model. Texas Heart Institute Journal, 2016 Dec 1;43(6):477-481.
Pollet M, Birnbaum Y, Nazeri A. Heart Block in a Pacemaker: Does This Mean Trouble? Texas Heart Institute Journal, 2016 Jun 1;43(3):270-1.
Safavi-Naeini P, Shanoon F, Nazeri A, Rasekh A, Saeed M, Razavi M, Massumi,A. Cryoballoon pressure waveform change during balloon inflation is not a reliable predictor of adequate pulmonary vein occlusion. Pacing Clinical Electrophysiology. 2014 Dec;37(12):1702-7.
Nazeri A, Ganapathy A, Massumi A, Massumi M, Constantine G, Raz S, Razavi M.Contact-force recovery can predict cardiac perforation during radiofrequency ablation.Pacing Clinical Electrophysiology. 2014 Sep;37(9):1129-32.
Massumi A, Chelu MG, Nazeri A, May SA, Afshar-Kharaghan H, Saeed M, Razavi M, Rasekh A, Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. American Journal of Cardiology. 2013 Mar 15;111(6):869-73.
Hojjati MR, Rozo JC, Nazeri A, Cheong BY, A rare pairing: myocardial non-compaction and congenital absence of pericardium. Texas Heart Institute Journal. 2013;40(4):500-1.
Ganjehei L, Nazeri A, Massumi A, Razavi M. “Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator “ .Texas Heart Institute Journal. 2012;39(4):568-70.
Ho SC, Razavi M, Nazeri A, Song G. “FBG sensor for contact level monitoring and prediction of perforation in cardiac ablation” Sensors (Basel). 2012;12(1):1002-13.
Nazeri A, Elayda MA, Dragnev L, Frank CM, Qu J, Afonso VX, Rasekh A, Saeed M, Cheng J, Shuraih M, Massumi A, Razavi M. “Heterogeneity of left ventricular signal characteristics in response to acute vagal stimulation during ventricular fibrillation in dogs” Texas Heart Institute Journal. 2011;38(6):621-6.
Ganjehei L, Massumi A, Nazeri A, Razavi M. “Pharmacologic management of arrhythmias” Texas Heart Institute Journal. 2011;38(4):344-9. Review.
Ganjehei L, Massumi A, Nazeri A, Razavi M. “Cardiac arrhythmias in women” Texas Heart Institute Journal 2011;38(2):157-9.
Bensler JM, Frank CM, Razavi M, Rasekh A, Saeed M, Haas PC, Nazeri A, Massumi A. “Tachycardia-mediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia” Texas Heart Institute Journal ,2010;37(6):695-8.
Nazeri A, Razavi M, Elayda MA, Lee VV, Massumi A, Wilson JM. “Race/ethnicity and the incidence of new-onset atrial fibrillation after isolated coronary artery bypass surgery.” Heart Rhythm. 2010 Oct;7(10):1458-63.
Nazeri A, Massumi A, Rasekh A, Saeed M, Frank C, Razavi M. “Cardiac resynchronization therapy in patients with right ventricular pacing-induced cardiomyopathy” Pacing Clinical Electrophysiology. 2010 Jan;33(1):37-40. Epub 2009 Oct 10.
Nazeri A, Massumi A, Wilson JM, Frank CM, Bensler M, Cheng J, Saeed M, Rasekh A, Razavi M. “Arrhythmogenicity of weight-loss supplements marketed on the Internet.” Heart Rhythm. 2009 May; 6(5):658-62.
Paisley RD, Arora HS, Nazeri A, Massumi A, Razavi M. “Migraine and vasodepressor syncope in a large family” Texas Heart Institute Journal. 2009;36(5):468-9.
Nazeri A, Rasekh A, Massumi A, Razavi M. “Coalescence of splines on a basket mapping catheter during ablation using a closed-loop irrigation catheter” Europace. 2009 Feb;11(2):258-9.
Nazeri A, Massumi A, Rasekh A, Saeed M, Frank C, Wilson JM, Lopez JA, Razavi M “Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony” Europace. 2009 Jan;11(1):86-8.
Nazeri A, Fakih M. “The effect of infectious disease (ID) consultation on the use of vancomycin in patients with two positive blood cultures for coagulase negative Staphylococcus” Infectious Disease in Clinical Practice, 16(1):20-22, January 2008.
Enayet I, Nazeri A, Johnson LB, Riederer K, Pawlak J, Saravolatz LD. “Community-associated methicillin-resistant Staphylococcus aureus causing chronic pneumonia” Clinical Infectious Disease, 42(7):e57-60, April 2006.
Nazeri I, Nazeri A; Shokoufi Sh. “Direct coronary stenting without pre-dilatation in selected patients with significant coronary artery disease” Archive of Iranian Medicine 2005, (8);202-205.
Contact-force recovery predicts the absence of cardiac perforation during steam pops.
Ganapathy AV, Nazeri A, Ashton J, Ganapathy KS, Safavi-Naeini P, Saeed M, Rasekh A,
Razavi M.J Interv Card Electrophysiol. 2020 Jun 13.
Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.
Nazeri A.Tex Heart Inst J. 2018 Jun 1;45(3):164-165. doi: 10.14503/THIJ-18-6678. eCollection